STERISHEALTHCAREPVTLTDADA8 Medicines
Jaipur page08048129013 boost@sterispharma.com
918955945010
Chat with us  

Chat with us on WhatsApp

×
Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCAREPVTLTDADA8 65b0b7e3912bef38d51b547d Medicines https://www.sterispharma.com
Home
medicines
Quote
Menu

Steris Healthcare Pvt Ltd, We are delighted to introduce ourselves as STERIS HEALTHCARE PVT LTD is a specialty pharmaceutical company formed in the February month of year 2015 by a group of extensively proficient pharmaceutical pr ...

Steris Healthcare Pvt Ltd, We are delighted to introduce ourselves as STERIS HEALTHCARE PVT LTD is a specialty pharmaceutical company formed in the February month of year 2015 by a group of e... read more

VIEW medicines
CONTACT US

Our Medicines

PIOSTERIS 30 Pioglitazone (30mg)Introduction:Type 2 diabetes mellitus (T2DM) presents a significant global health challenge, necessitating effective management strategies to mitigate its complications and improve patient outcomes. In recent years, Pioglitazone has emerged as a valuable therapeutic option for individuals with T2DM. PIOSTERIS 30, featuring Pioglitazone at a dosage of 30mg, represents a pivotal advancement in the armamentarium of antidiabetic medications. This article explores the features, efficacy, safety profile, and clinical implications of PIOSTERIS 30 in the management of T2DM.Understanding Pioglitazone:Pioglitazone belongs to the class of thiazolidinediones (TZDs), which exert their antidiabetic effects by improving insulin sensitivity in peripheral tissues such as adipose tissue, skeletal muscle, and liver. Through activation of peroxisome proliferator-activated receptor gamma (PPAR-γ) receptors, Pioglitazone enhances glucose uptake and utilization, leading to improved glycemic control in patients with T2DM.Key Features of PIOSTERIS 30:PIOSTERIS 30 is a pharmaceutical formulation containing Pioglitazone at a standardized dosage of 30mg per tablet. This dosage strength offers clinicians the flexibility to tailor treatment regimens to individual patient needs, ensuring optimal glycemic control. The formulation of PIOSTERIS 30 ensures consistency and reliability in dosing, facilitating effective diabetes management.Efficacy in Glycemic Control:Clinical studies have demonstrated the efficacy of Pioglitazone, including PIOSTERIS 30, in improving glycemic control in patients with T2DM. Pioglitazone has been shown to reduce hemoglobin A1c (HbA1c) levels, fasting plasma glucose, and postprandial glucose excursions, leading to improvements in overall glucose regulation. Additionally, Pioglitazone may offer benefits beyond glycemic control, including improvements in insulin sensitivity and lipid profiles. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 https://www.sterisonline.com/product/piosteris-30-134190
Buy Now
Add to cart
View Details
PIOSTERIS 30

INR 67 INR 95
You Save: INR 29.47%

View Details
PIOSTERIS 15 Pioglitazone (15mg)Introduction:Diabetes mellitus is a prevalent chronic condition that requires effective management to prevent complications and improve quality of life. Among the arsenal of medications available for the treatment of type 2 diabetes mellitus (T2DM), Pioglitazone has emerged as a valuable therapeutic option. PIOSTERIS 15, featuring Pioglitazone at a dosage of 15mg, represents a significant advancement in the management of T2DM. This article explores the features, efficacy, safety profile, and clinical implications of PIOSTERIS 15 in diabetes care.Understanding Pioglitazone:Pioglitazone belongs to the class of thiazolidinediones (TZDs), which act primarily by improving insulin sensitivity in peripheral tissues such as adipose tissue, skeletal muscle, and liver. By activating peroxisome proliferator-activated receptor gamma (PPAR-γ) receptors, Pioglitazone enhances glucose uptake and utilization, leading to improved glycemic control in patients with T2DM.Key Features of PIOSTERIS 15:PIOSTERIS 15 is a pharmaceutical formulation containing Pioglitazone at a standardized dosage of 15mg per tablet. This dosage strength provides clinicians with the flexibility to tailor treatment regimens to individual patient needs, ensuring optimal glycemic control. The formulation of PIOSTERIS 15 ensures consistency and reliability in dosing, facilitating effective diabetes management. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 https://www.sterisonline.com/product/piosteris-15-133429
Buy Now
Add to cart
View Details
PIOSTERIS 15

INR 39 INR 55
You Save: INR 29.09%

View Details
PAFAGOLD M 500 Dapaflozin 10 mg + Metformin SR 500 mgIntroduction:The management of type 2 diabetes mellitus (T2DM) often requires a multifaceted approach, combining lifestyle modifications, dietary interventions, and pharmacotherapy. In recent years, the combination of multiple therapeutic agents with complementary mechanisms of action has gained prominence in optimizing glycemic control. PAFAGOLD M 500, featuring Dapagliflozin 10mg and Metformin sustained-release (SR) 500mg, represents a novel strategy in diabetes care. This article explores the rationale behind the combination, its efficacy, safety profile, and clinical implications.Understanding the Components:PAFAGOLD M 500 integrates two key components: Dapagliflozin and Metformin sustained-release (SR). Dapagliflozin, an SGLT2 inhibitor, inhibits renal glucose reabsorption, leading to increased urinary glucose excretion. Metformin SR, a biguanide, primarily reduces hepatic glucose production and enhances insulin sensitivity. By combining these agents, PAFAGOLD M 500 targets both fasting and postprandial hyperglycemia, offering comprehensive glycemic control.Efficacy in Glycemic Control:Clinical studies have demonstrated the efficacy of PAFAGOLD M 500 in improving glycemic control in patients with T2DM. The combination of Dapagliflozin and Metformin SR has been shown to reduce hemoglobin A1c (HbA1c) levels and fasting plasma glucose, leading to significant improvements in overall glucose regulation. Additionally, the sustained-release formulation of Metformin enhances tolerability and reduces gastrointestinal side effects compared to immediate-release formulations.Safety Profile:PAFAGOLD M 500 exhibits a favorable safety profile, with adverse effects typically mild to moderate in severity. Common side effects may include gastrointestinal symptoms such as nausea, diarrhea, or abdominal discomfort, which are often transient and diminish with continued therapy. Additionally, Dapagliflozin and Metformin have complementary mechanisms of action, minimizing the risk of hypoglycemia and weight gain associated with some antidiabetic medications. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 https://www.sterisonline.com/product/pafagold-m-500-134322
Buy Now
Add to cart
View Details
PAFAGOLD M 500

INR 126 INR 180
You Save: INR 30%

View Details
View All Medicines
about Steris Pharma

about our organization

Steris Healthcare Pvt Ltd, We are delighted to introduce ourselves as STERIS HEALTHCARE PVT LTD is a specialty pharmaceutical company formed in the February month of year 2015 by a group of extensively proficient pharmaceutical pr...Read More

  • 922

    Medicines Available

lATEST NEWS

PANCREATE CLEAR Pancreatin (192mg) . Bile Constituents (25mg), Activated Dimethicone(40mg...

Read More
Read More

TOPERITIME 150 Tolperisone Hcl (150mg) TOPERITIME 150 is a muscle relaxant that utilizes ...

Read More
Read More

DIOWELPREX ER 500 Divalproex ER (500mg) DIOWELPREX ER 500 is a medication containing Diva...

Read More
Read More
VIEW ALL UPDATES

Request a Call Back

Any Questions About Us?


If you have any kind of query, please don't hesitate to contact us on our Email and you can also contact by calling page08048129013


Chat with us  

Customers

Opening Hours

    Subscribe Us

    Subscribe to our newsletter!
    Steris Pharma

    Social share